11021-14-0
11021-14-0 結(jié)構(gòu)式
基本信息
人參皂苷RC
GINSENOSIDE RC
20-[(6-O-alpha-L-arabinofuranosyl-beta-D-glucopyranosyl)oxy]-12beta-hydroxydammar-24-en-3beta-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside
GINSENOSIDE FROM GINSENG ROOT (PANAX*QUI NQUEFOLIUM
ginsenoside-rc from panax quinquefolium (american ginseng)root
Ginsenoside Rc (CAS# 11021-14-0)
20-[(6-O-alpha-L-Arabinofuranosyl-beta-D-glucopyranosyl)oxy]-12b-hydroxydammar-24-en-3b-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside
GINSENOSIDE RC WITH HPLC
arabinofuranosyl-β-D-glucopyranosyl)oxy]-12-
glucopyranosyl-
hydroxydammar-24-en-3-yl2-O-β-D-
Panaxoside Rc
[20-[(6-O-α-L-Arabinofuranosyl-β-D-glucopyranosyl)oxy]-12β-hydroxydammar-24-en-3β-yl]2-O-β-D-glucopyranosyl-β-D-glucopyranoside
3β-[2-O-(β-D-Glucopyranosyl)-β-D-glucopyranosyloxy]-20-[6-O-(α-L-arabinofuranosyl)-β-D-glucopyranosyloxy]dammara-24-ene-12β-ol
物理化學(xué)性質(zhì)
應(yīng)用領(lǐng)域
| 報價日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS號 | 包裝 | 價格 |
| 2024/11/08 | HY-N0042 | 人參皂甙 Rc Ginsenoside Rc | 11021-14-0 | 5mg | 650元 |
| 2024/11/08 | HY-N0042 | 人參皂甙 Rc Ginsenoside Rc | 11021-14-0 | 10mg | 1100元 |
| 2024/11/08 | HY-N0042 | 人參皂甙 Rc Ginsenoside Rc | 11021-14-0 | 10 mM * 1 mLin DMSO | 1306元 |
常見問題列表
|
TNF-α
|
IL-1β
|
Ginsenoside Rc, one of major Ginsenosides from Panax ginseng, enhances γ-aminobutyric acid (GABA) receptor A (GABA A )-mediated ion channel currents. Ginsenoside Rc enhances GABA-mediated ion currents in oocytes expressing the GABA A receptor. Ginsenoside Rc significantly inhibits the expression of macrophage-derived cytokines, such as TNF-α and IL-1β. Ginsenoside Rc also markedly suppresses the activation of TANK-binding kinase 1/IκB kinase ε/interferon regulatory factor-3 and p38/ATF-2 signaling in activated RAW264.7 macrophages, human synovial cells, and HEK293 cells. Ginsenoside Rc exerts its anti-inflammatory actions by suppressing TANK-binding kinase 1/IκB kinase ε/interferon regulatory factor-3 and p38/ATF-2 signaling. Ginsenoside Rc suppresses the nuclear translocation of phospho-ATF-2 and phospho-FRA-1, whereas the translocation of p65 at its peak time points (30 and 60 min) is not decreased by Ginsenoside Rc treatment. Ginsenoside Rc regulates the expression of the proinflammatory cytokine TNF-α, which is produced by macrophages, by suppressing AP-1 activation.